Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17505016rdf:typepubmed:Citationlld:pubmed
pubmed-article:17505016lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:17505016lifeskim:mentionsumls-concept:C0081939lld:lifeskim
pubmed-article:17505016lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:17505016lifeskim:mentionsumls-concept:C1422839lld:lifeskim
pubmed-article:17505016lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:17505016lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:17505016lifeskim:mentionsumls-concept:C1705294lld:lifeskim
pubmed-article:17505016lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:17505016pubmed:issue6lld:pubmed
pubmed-article:17505016pubmed:dateCreated2007-9-5lld:pubmed
pubmed-article:17505016pubmed:abstractTextJunctional adhesion molecule-A (JAM-A) is a transmembrane protein expressed at tight junctions of endothelial and epithelial cells and on the surface of platelets and leukocytes. The role of JAM-A in leukocyte transmigration in vivo was directly investigated by intravital microscopy using both a JAM-A-neutralizing monoclonal antibody (mAb) (BV-11) and JAM-A-deficient (knockout [KO]) mice. Leukocyte transmigration (but not adhesion) through mouse cremasteric venules as stimulated by interleukin 1beta (IL-1beta) or ischemia/reperfusion (I/R) injury was significantly reduced in wild-type mice treated with BV-11 and in JAM-A KO animals. In contrast, JAM-A blockade/genetic deletion had no effect on responses elicited by leukotriene B(4) (LTB(4)) or platelet-activating factor (PAF). Furthermore, using a leukocyte transfer method and mice deficient in endothelial-cell JAM-A, evidence was obtained for the involvement of endothelial-cell JAM-A in leukocyte transmigration mediated by IL-1beta. Investigation of the functional relationship between JAM-A and PECAM-1 (CD31) determined that dual blockade/deletion of these proteins does not lead to an inhibitory effect greater than that seen with blockade/deletion of either molecule alone. The latter appeared to be due to the fact that JAM-A and PECAM-1 can act sequentially to mediate leukocyte migration through venular walls in vivo.lld:pubmed
pubmed-article:17505016pubmed:languageenglld:pubmed
pubmed-article:17505016pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17505016pubmed:citationSubsetAIMlld:pubmed
pubmed-article:17505016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17505016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17505016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17505016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17505016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17505016pubmed:statusMEDLINElld:pubmed
pubmed-article:17505016pubmed:monthSeplld:pubmed
pubmed-article:17505016pubmed:issn0006-4971lld:pubmed
pubmed-article:17505016pubmed:authorpubmed-author:HaskardDorian...lld:pubmed
pubmed-article:17505016pubmed:authorpubmed-author:KrombachFritz...lld:pubmed
pubmed-article:17505016pubmed:authorpubmed-author:VoisinMathieu...lld:pubmed
pubmed-article:17505016pubmed:authorpubmed-author:DejanaElisabe...lld:pubmed
pubmed-article:17505016pubmed:authorpubmed-author:CoradaMonicaMlld:pubmed
pubmed-article:17505016pubmed:authorpubmed-author:KhandogaAndre...lld:pubmed
pubmed-article:17505016pubmed:authorpubmed-author:NoursharghSus...lld:pubmed
pubmed-article:17505016pubmed:authorpubmed-author:ScheiermannCh...lld:pubmed
pubmed-article:17505016pubmed:authorpubmed-author:WoodfinAbigai...lld:pubmed
pubmed-article:17505016pubmed:authorpubmed-author:ReichelChrist...lld:pubmed
pubmed-article:17505016pubmed:issnTypePrintlld:pubmed
pubmed-article:17505016pubmed:day15lld:pubmed
pubmed-article:17505016pubmed:volume110lld:pubmed
pubmed-article:17505016pubmed:ownerNLMlld:pubmed
pubmed-article:17505016pubmed:authorsCompleteYlld:pubmed
pubmed-article:17505016pubmed:pagination1848-56lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:meshHeadingpubmed-meshheading:17505016...lld:pubmed
pubmed-article:17505016pubmed:year2007lld:pubmed
pubmed-article:17505016pubmed:articleTitleJAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration.lld:pubmed
pubmed-article:17505016pubmed:affiliationCardiovascular Medicine Unit, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.lld:pubmed
pubmed-article:17505016pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17505016pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:17505016pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:16456entrezgene:pubmedpubmed-article:17505016lld:entrezgene
entrez-gene:18613entrezgene:pubmedpubmed-article:17505016lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17505016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17505016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17505016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17505016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17505016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17505016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17505016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17505016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17505016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17505016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17505016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17505016lld:pubmed